1. Home
  2. MBX vs SWBI Comparison

MBX vs SWBI Comparison

Compare MBX & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBX
  • SWBI
  • Stock Information
  • Founded
  • MBX 2018
  • SWBI 1852
  • Country
  • MBX United States
  • SWBI United States
  • Employees
  • MBX N/A
  • SWBI N/A
  • Industry
  • MBX
  • SWBI Ordnance And Accessories
  • Sector
  • MBX
  • SWBI Industrials
  • Exchange
  • MBX NYSE
  • SWBI Nasdaq
  • Market Cap
  • MBX 379.7M
  • SWBI 429.0M
  • IPO Year
  • MBX 2024
  • SWBI N/A
  • Fundamental
  • Price
  • MBX $9.63
  • SWBI $8.73
  • Analyst Decision
  • MBX Strong Buy
  • SWBI Buy
  • Analyst Count
  • MBX 5
  • SWBI 2
  • Target Price
  • MBX $37.40
  • SWBI $12.75
  • AVG Volume (30 Days)
  • MBX 217.8K
  • SWBI 759.5K
  • Earning Date
  • MBX 08-16-2025
  • SWBI 06-18-2025
  • Dividend Yield
  • MBX N/A
  • SWBI 5.96%
  • EPS Growth
  • MBX N/A
  • SWBI N/A
  • EPS
  • MBX N/A
  • SWBI 0.30
  • Revenue
  • MBX N/A
  • SWBI $474,661,000.00
  • Revenue This Year
  • MBX N/A
  • SWBI N/A
  • Revenue Next Year
  • MBX N/A
  • SWBI $3.86
  • P/E Ratio
  • MBX N/A
  • SWBI $29.08
  • Revenue Growth
  • MBX N/A
  • SWBI N/A
  • 52 Week Low
  • MBX $4.81
  • SWBI $8.38
  • 52 Week High
  • MBX $27.50
  • SWBI $16.85
  • Technical
  • Relative Strength Index (RSI)
  • MBX N/A
  • SWBI 34.65
  • Support Level
  • MBX N/A
  • SWBI $10.48
  • Resistance Level
  • MBX N/A
  • SWBI $10.93
  • Average True Range (ATR)
  • MBX 0.00
  • SWBI 0.32
  • MACD
  • MBX 0.00
  • SWBI -0.05
  • Stochastic Oscillator
  • MBX 0.00
  • SWBI 3.29

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

Share on Social Networks: